Text this: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _    _    _    _     ____      _____     _____   
| \  / || | || | ||  |  _ \\   |  ___||  /  ___|| 
|  \/  || | || | ||  | |_| ||  | ||__   | // __   
| .  . || | \\_/ ||  | .  //   | ||__   | \\_\ || 
|_|\/|_||  \____//   |_|\_\\   |_____||  \____//  
`-`  `-`    `---`    `-` --`   `-----`    `---`